[go: up one dir, main page]

DE60107292D1 - Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin - Google Patents

Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin

Info

Publication number
DE60107292D1
DE60107292D1 DE60107292T DE60107292T DE60107292D1 DE 60107292 D1 DE60107292 D1 DE 60107292D1 DE 60107292 T DE60107292 T DE 60107292T DE 60107292 T DE60107292 T DE 60107292T DE 60107292 D1 DE60107292 D1 DE 60107292D1
Authority
DE
Germany
Prior art keywords
fluorophenyl
trans
methylpiperidine
hydroxymethyl
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60107292T
Other languages
English (en)
Other versions
DE60107292T2 (de
Inventor
Rafael Foguet
Jorge Ramentol
Ines Petschen
Juan Sallares
X Camps
M Raga
M Castello
P Armengol
Diego Fernandez-Cano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Application granted granted Critical
Publication of DE60107292D1 publication Critical patent/DE60107292D1/de
Publication of DE60107292T2 publication Critical patent/DE60107292T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60107292T 2001-01-04 2001-01-04 Verfahren zur Herstellung von (+)-trans-4-p-Fluorophenyl-3-hydroxymethyl-1-methylpiperidin Expired - Fee Related DE60107292T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2001/000049 WO2002053537A1 (en) 2001-01-04 2001-01-04 Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine

Publications (2)

Publication Number Publication Date
DE60107292D1 true DE60107292D1 (de) 2004-12-23
DE60107292T2 DE60107292T2 (de) 2005-12-01

Family

ID=8164242

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107292T Expired - Fee Related DE60107292T2 (de) 2001-01-04 2001-01-04 Verfahren zur Herstellung von (+)-trans-4-p-Fluorophenyl-3-hydroxymethyl-1-methylpiperidin

Country Status (17)

Country Link
US (1) US6881845B2 (de)
EP (1) EP1347960B1 (de)
JP (1) JP2004520333A (de)
KR (1) KR20030067742A (de)
AT (1) ATE282594T1 (de)
BR (1) BR0116721A (de)
CA (1) CA2433605A1 (de)
DE (1) DE60107292T2 (de)
DK (1) DK1347960T3 (de)
ES (1) ES2232588T3 (de)
IL (1) IL156768A0 (de)
MX (1) MXPA03006057A (de)
NO (1) NO20033049L (de)
NZ (1) NZ526874A (de)
PT (1) PT1347960E (de)
TW (1) TW593279B (de)
WO (1) WO2002053537A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422055A1 (en) * 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
DE10240026A1 (de) * 2002-08-27 2004-03-11 Merck Patent Gmbh Verfahren zur Herstellung von Monoalkylaminoketonen
WO2004043921A1 (en) * 2002-11-11 2004-05-27 Natco Pharma Limited Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines.
WO2005063707A1 (en) * 2003-12-26 2005-07-14 Natco Pharma Limited Enantiospecific process for the preparation of paroxetine intermediate
WO2007089193A1 (en) * 2006-02-02 2007-08-09 Astrazeneca Ab A process for preparing 2-hydroxy-3- [5- (morpholin-4-ylmethyl)pyridin-2-yl] lh-indole-5-carbonitrile as a free base or salts thereof
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
WO2022269643A1 (en) * 2021-06-25 2022-12-29 Vihita Chem Private Limited An improved process for the preparation of intermediate for paroxetine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223334B1 (de) * 1985-08-10 1991-07-10 Beecham Group Plc Verfahren zur Herstellung von Arylpiperidincarbinol
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
BR9608471A (pt) 1995-05-17 1998-12-29 Novo Nordisk As Processo para a preparação de um composto
EP1384711A1 (de) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optische Trennung eines Piperidin-Derivates
IL133140A0 (en) * 1997-05-29 2001-03-19 Smithkline Beecham Corp Novel process for the preparation of 4-aryl-piperidines
EP1124802A1 (de) * 1998-11-02 2001-08-22 Synthon B.V. Verfahren zur herstellung von 4-arylpiperidin-3-carbinolen und verwandte verbindungen

Also Published As

Publication number Publication date
MXPA03006057A (es) 2004-01-26
ATE282594T1 (de) 2004-12-15
DE60107292T2 (de) 2005-12-01
NO20033049D0 (no) 2003-07-03
EP1347960A1 (de) 2003-10-01
WO2002053537A8 (en) 2002-08-08
WO2002053537A1 (en) 2002-07-11
BR0116721A (pt) 2003-12-23
IL156768A0 (en) 2004-02-08
EP1347960B1 (de) 2004-11-17
PT1347960E (pt) 2005-03-31
DK1347960T3 (da) 2005-03-21
NO20033049L (no) 2003-08-18
CA2433605A1 (en) 2002-07-11
TW593279B (en) 2004-06-21
KR20030067742A (ko) 2003-08-14
JP2004520333A (ja) 2004-07-08
US6881845B2 (en) 2005-04-19
NZ526874A (en) 2005-07-29
ES2232588T3 (es) 2005-06-01
US20040215020A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
ATE410412T1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
ATE407127T1 (de) Verfahren zur herstellung von beraprost und dessen salzen
DE69915713D1 (de) Verfahren zur herstellung von citalopram
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
DE50309260D1 (de) Verfahren zur herstellung von bicalutamid
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE59811798D1 (de) Verfahren zur herstellung von 5-aminomethyl-2-chlorpyridinen
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE265421T1 (de) Verfahren zur herstellung von midodrin
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
ATE425143T1 (de) Verfahren zur herstellung von indolen
DE60229261D1 (de) Verfahren zur herstellung von säureanhydrid
ATE365706T1 (de) Verfahren zur herstellung von bis (trifluormethyl)imido-salzen
DE69514512D1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
ATE325111T1 (de) Verfahren zur herstellung von 15-pentadecanolid
ATE309226T1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE60007137D1 (de) Verfahren zur herstellung von 2-arylvinylalkylethern und 1,4-diaryl-2-fluor-2-butenen
ATE281428T1 (de) Verfahren zur herstellung von methoxyimino- essigsäureamiden
DE60107098D1 (de) Verfahren zur herstellung von halo-4-phenoxy-chinolinen
ATE321028T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee